Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 10Lymphoma 9Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Myelodysplastic Syndromes 6Multiple Myeloma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hematologic Neoplasms 4Congenital Abnormalities 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Biphenotypic, Acute 3Waldenstrom Macroglobulinemia 2Recurrence 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2

Interventions

Cisplatin 5Cetuximab 3Radiotherapy 2Petrolatum 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2temoporfin 1talazoparib 1ruxolitinib 1peginterferon alfa-2a 1olaparib 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cemiplimab 1cedazuridine 1atezolizumab 1aldesleukin 1Vorinostat 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiation 1Narrow Band Imaging 1Interviews as Topic 1Interleukin-2 1Gefitinib 1Decitabine 1DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Squamous Cell × fludarabine phosphate × Clear all
NCT00937300 2011-11-23

T-cell Based Immunotherapy for Head and Neck Cancer

Herlev Hospital

Phase 1 Withdrawn
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡